Effect of Febuxostat on Blood Pressure
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 121 participants.
Also called NCT01496469
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 121 participants
- Sponsor
- Registry
-
NCT01496469 -
U1111-1124-4638
-
- Other papers using this trial's data
- Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01496469. Randomized; quadruple masking; primary purpose treatment. Start 2012-02 (registry gives no type); primary completion 2014-08 (actual). Results posted on 2015-08-31.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Febuxostat on Blood Pressure
- Condition
- Hypertension
- Intervention (Drug)
- Febuxostat
- Intervention (Drug)
- Placebo
- Lead sponsor
- Takeda
Record details
- Record id
cardio:ct-nct01496469- Content hash
74498a745ba45682376e8164685abce5a1ae6a2b41558fead996b9e85c38981e